CalciMedica CALC
NASDAQ CALC
$1.61 -0.07 (-4.17%)
As of: Sep 29, 2026 · 3:59 PM EDT

CalciMedica (CALC) EBIT Margin (2024)

Updated

CalciMedica's EBIT Margin was -2884.11% in Q4 2024, down 252.92 percentage points from the prior quarter.

Analysis

CalciMedica (CALC) EBIT Margin (2024) Analysis & Trends

For FY2024, EBIT Margin at CalciMedica came in at -2386.98%.

  • Per Business Quant data, CALC's EBIT Margin in the three quarters before Q4 2024 was -2631.19% (Q3 2024), -2374.18% (Q2 2024) and -1878.50% (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 CalciMedica 5.81 Mn -12.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,884.11%
Sep 30, 2024 -2,631.19%
Jun 30, 2024 -2,374.18%
Mar 31, 2024 -1,878.50%
API Access

CalciMedica EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CALC&period=max&api_key=YOUR_API_KEY